medigraphic.com

2004, Number 3

<< Back Next >>

Arch Cardiol Mex 2004; 74 (3)

Diminished vascular density in the aortic wall. Morphological and functional characteristics of atherosclerosis

Acoltzin VC, Maldonado VI, Rodríguez CL, Muñiz MJJ

Language: Spanish
References: 24
Page: 176-180
PDF size: 91.27 Kb.


ABSTRACT

Purpose:To determine disproportion in thicknesses of the vascular wall and vasa vasorum in eight fragments of human aorta because of the irregular distribution of atherosclerosis in arterial walls. Method: The length and thickness of the wall and its layers were measured and the vasa vasorum were conted. Vascular density, considered as the number of vessels per square millimeter in healthy and diseased areas, was calculated along with mean value, variance, standard deviation and the confidence interval for values and null hypotesis. Variances were analyzed, and the comparative and paired “t” test was applied. Results: There were differences in thicknesses of the healthy (27 :m) and diseased (120.5 :m) intima (p < 0.001) and between the healthy (125.2 :m) and diseased (102.3 :m) media (P < 0.001). Vascular density was higher in healthy fragments (mean ± CI 99% = 4.40 ± 1.4 vs 2.20 ± 0.8, = < 0.001 for Ha; 0 ± 1.0775 for Ho; paired “t” 2.1 ± 1.1, P < 0.01), and higher compared to the healthy intima area (31.6 vs 5.1, P < 0.01). There were no differences compared to the media layer area. The relation between the number of vessels and the length of the vascular segments was greater in the healthy fragments (mean ± CI 95% = 4.9 ± 1.02 vs 3.5 ± 0.68; 1.4 difference, P < 0.05). Conclusion: Vascular density is lower in the atherosclerotic aortic wall than in the healthy aorta and this could initiate the pathologic process.


REFERENCES

  1. Corday E: Why some physicians have concerns about cholesterol. A warenes program. Am J Cardiol 1989; 63: 497-502.

  2. Ross R: Teorías que explican el proceso aterógeno. Factores que influyen en la aterogénesis. En: Hurst W: El Corazón. 6ª ed. México. Interamericana Mc Graw-Hill, 1988: 885-902.

  3. Wood P: Diseases of the Heart and Circulation. Philadelphia. J.B. Lippincott Company, 1968: 813.

  4. Harrison TR: Enfermedades isquémicas del corazón. México. Salvat, 1970: 21-43.

  5. Goldstein J: Genetic aspects of hyperlipidaemia in coronary Heart disease. En: Braunwald E: The Heart. Failure and Infarction. New York. H.P. Publishing Co Inc, 1973: 205-218.

  6. Goldstein J, Brown M: Nobel Lecture. Dec 9, 1985.

  7. Livshits G: Multivariate analysis of twenty year follow up of the Donolo-Tel Aviv prospective coronary artery disease study and usefulness of High Density Lipoprotein Cholesterol percentage. Am J Cardiol 1989; 63: 676-681.

  8. Maciejko J: Apolipoprotein A1 as a marker of angiographically assessed coronary artery disease. New Engl J Med 1983; 309: 385-389.

  9. Kottke BA: Assessment of Apolipoprotein A1 as a discriminator of coronary artery disease. Am J Cardiol 1986; 57: 11C-17C.

  10. Tasaki H: Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects. Am J Cardiol 1989; 63: 1441-1445.

  11. Acoltzin C, Lezama Y: Lack of Apoprotein A1 in patients recovering from myocardial infarction. Am J Cardiol 1990; 66: 124.

  12. Kashyap M: Basic considerations in the reversal of atherosclerosis: significance of high density lipoprotein in stimulating reverse cholesterol transport. Am J Cardiol 63: 56H-59H.

  13. Okuyama K, Yaegashi H, Takahashi T, Sasaki H, Mori Sh: The development of vasa vasorum of the human aorta in various conditions. Arch Patol Lab Med 1988; 112: 721-725.

  14. Williams JK, Heistad DD: The vasa vasorum of the arteries. J MalVasc 1996; 21(Suppl C): 266-269.

  15. The expert panel: Report of the national cholesterol education program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-39.

  16. Scotland RS, Vallance PJ, Ahluwalia A: Endogenous factors involved in regulation of tone of arterial vasa vasorum: implications for conduit vessel physiology. Cardiovasc Res 2000; 46(3): 403-11.

  17. Baker SG, Talbert A, Cottom S, Baskerville RA, Martin JF: Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Atheroscler-Thromb 1993; 13(1): 70-77.

  18. Santilli SM, Wernsing SE, Lee ES: The effect of supplemental oxygen on the transarterial wall oxygen gradients at a prosthetic vascular graft to artery anastomosis in the rabbit. Ann Vasc Surg 2001; 15: 435-442.

  19. Kai H, Kawahara F, Tokuda K, Shibata R, Kusaba K, Miiyama H, et al: Coexistence of hipercholesterolemia and hypertension impairs adventitial vascularization. Hypertension 2002; 39: 455-459.

  20. Aburatani H, Matsumoto A, Kodama T, Fukazawa EH, Itakura H: Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of Probucol-treated rabbits. Am J Cardiol 1988; 62: 60B-65B.

  21. Mas-Oliva J: Modulación de la función de membrana celular por colesterol y su relación con enfermedad. Gac Med Méx 1994: 130(6): 438-445.

  22. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W jr: A definition of advances types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from committee on vascular lesions of the council on atherosclerosis. American Heart Association. Circulation 1995; 92(5): 1355-74. http://www.amhrt.org/Scientific/statement/1995/17950005.html

  23. Baskerville PA, Martin JF: The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit wich regress on generation of “neoadventitia”. Atherosclerosis 1994; 105: 131-144.

  24. Pisco JM, Correia M, Esperança Pina JA, De Sousa LA: Vasa vasorum changes following stent placement in experimental arterial stenosis. J Vasc Radiol 1993; 4: 269-273.




2020     |     www.medigraphic.com